AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announces that U.S. Food and Drug...
Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, announced that it has acquired XenoTech, a provider of...
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced CE Mark approval for OncoSeek® Multi-Cancer Detection Test and is now...
NeoImmuneTech, Inc, a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells in...
